Subregion-specific decreases in hippocampal serotonin transporter protein expression and function associated with endophenotypes of depression

Hippocampus

Volumn 24, Issue 4, 2014, Pages 493-501

  Tang, Man ^a   He, Tao ^a   Sun, Xiao ^b   Meng, Qing Yan ^c   Diao, Yao ^a   Lei, Jie Yu ^a   He, Xiao Jing ^a   Chen, Lei ^a   Sang, Xiu Bo ^a   Zhao, Shulei ^d  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SHENYANG MEDICAL COLLEGE   (China)

^c Northern Hospital   (China)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Anhedonia; Behavioral despair; Corticosteroid; Hippocampus; Synaptosomal 5 HT uptake

Indexed keywords

CORTICOSTEROID; SEROTONIN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, MOUSE;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ENDOPHENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TAIL SUSPENSION TEST; ANIMAL; DISEASE MODEL; HIPPOCAMPUS; INBRED MOUSE STRAIN; METABOLISM; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SYNAPTOSOME;

ADRENAL CORTEX HORMONES; ANHEDONIA; ANIMALS; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; DENTATE GYRUS; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; ENDOPHENOTYPES; HIPPOCAMPUS; MALE; MICE; MICE, INBRED STRAINS; ORGAN SIZE; RANDOM ALLOCATION; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMES;

EID: 84904240825     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22242     Document Type: Article

References (75)

1. Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K, Matsuda T. 2008. Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 55:1355-1363.
2. Airan RD, Meltzer LA, Roy M, Gong Y, Chen H, Deisseroth K. 2007. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science 317:819-823.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121-133.
4. Austin MC, Whitehead RE, Edgar CL, Janosky JE, Lewis DA. 2002. Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide. Neuroscience 114:807-815.
5. Baganz N, Horton R, Martin K, Holmes A, Daws LC. 2010. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: Organic cation transporter 3, the smoking gun. J Neurosci 30:15185-15195.
6. Barr JL, Forster GL. 2011. Serotonergic neurotransmission in the ventral hippocampus is enhanced by corticosterone and altered by chronic amphetamine treatment. Neuroscience 182:105-114.
7. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. 1999. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19:10494-10501.
8. Benmansour S, Owens WA, Cecchi M, Morilak DA, Frazer A. 2002. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22:6766-6772.
9. Berton O, Nestler EJ. 2006. New approaches to antidepressant drug discovery: Beyond monoamines. Nat Rev Neurosci 7:137-151.
10. Bhagwagar Z, Murthy N, Selvaraj S, Hinz R, Taylor M, Fancy S, Grasby P, Cowen P. 2007. 5-HTT binding in recovered depressed patients and healthy volunteers: A positron emission tomography study with [11C]DASB. Am J Psychiatry 164:1858-1865.
11. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
12. Campbell S, Marriott M, Nahmias C, MacQueen GM. 2004. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 161:598-607.
13. Carroll BJ, Martin FI, Davies B. 1968. Resistance to suppression by dexamethasone of plasma 11-O.H.C.S. levels in severe depressive illness. Br Med J 3:285-287.
14. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301:386-389.
15. Daniele A, Divella R, Paradiso A, Mattioli V, Romito F, Giotta F, Casamassima P, Quaranta M. 2011. Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: Causes and treatment with antidepressant. In Vivo 25:895-901.
16. David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M. 2003. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl) 166:373-382.
17. David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I, Drew M, Craig DA, Guiard BP, Guilloux JP, Artymyshyn RP, Gardier AM, Gerald C, Antonijevic IA, Leonardo ED, Hen R. 2009. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62:479-493.
18. Dinan TG. 1994. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br J Psychiatry 164:365-371.
19. Droste SK, de Groote L, Atkinson HC, Lightman SL, Reul JM, Linthorst AC. 2008. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 149:3244-3253.
20. Ducottet C, Griebel G, Belzung C. 2003. Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice. Prog Neuropsychopharmacol Biol Psychiatry 27:625-631.
21. Elizalde N, Garcia-Garcia AL, Totterdell S, Gendive N, Venzala E, Ramirez MJ, Del Rio J, Tordera RM. 2010. Sustained stress-induced changes in mice as a model for chronic depression. Psychopharmacology (Berl) 210:393-406.
22. Elizalde N, Gil-Bea FJ, Ramirez MJ, Aisa B, Lasheras B, Del Rio J, Tordera RM. 2008. Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: Effect of antidepressant treatment. Psychopharmacology (Berl) 199:1-14.
23. Fernandez F, Coomans V, Mormede P, Chaouloff F. 2001. Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains. Endocr Regul 35:119-126.
24. Fernandez F, Sarre S, Launay JM, Aguerre S, Guyonnet-Duperat V, Moisan MP, Ebinger G, Michotte Y, Mormede P, Chaouloff F. 2003. Rat strain differences in peripheral and central serotonin transporter protein expression and function. Eur J Neurosci 17:494-506.
25. Gould NF, Holmes MK, Fantie BD, Luckenbaugh DA, Pine DS, Gould TD, Burgess N, Manji HK, Zarate CA Jr. 2007. Performance on a virtual reality spatial memory navigation task in depressed patients. Am J Psychiatry 164:516-519.
26. Heim C, Binder EB. 2012. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol 233:102-111.
27. Herman JP, Cullinan WE, Morano MI, Akil H, Watson SJ. 1995. Contribution of the ventral subiculum to inhibitory regulation of the hypothalamo-pituitary-adrenocortical axis. J Neuroendocrinol 7:475-482.
28. Ichimiya T, Suhara T, Sudo Y, Okubo Y, Nakayama K, Nankai M, Inoue M, Yasuno F, Takano A, Maeda J, Shibuya H. 2002. Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biol Psychiatry 51:715-722.
29. Jiang W, Zhang Y, Xiao L, Van Cleemput J, Ji SP, Bai G, Zhang X. 2005. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115:3104-3116.
30. Joels M. 2008. Functional actions of corticosteroids in the hippocampus. Eur J Pharmacol 583:312-321.
31. Joels M, Karst H, Krugers HJ, Lucassen PJ. 2007. Chronic stress: Implications for neuronal morphology, function and neurogenesis. Front Neuroendocrinol 28:72-96.
32. Joensuu M, Tolmunen T, Saarinen PI, Tiihonen J, Kuikka J, Ahola P, Vanninen R, Lehtonen J. 2007. Reduced midbrain serotonin transporter availability in drug-naive patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging. Psychiatry Res 154:125-131.
33. Keeney A, Jessop DS, Harbuz MS, Marsden CA, Hogg S, Blackburn-Munro RE. 2006. Differential effects of acute and chronic social defeat stress on hypothalamic-pituitary-adrenal axis function and hippocampal serotonin release in mice. J Neuroendocrinol 18:330-338.
34. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. 2003. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095-3105.
35. Koepsell H, Lips K, Volk C. 2007. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251.
36. Krishnan V, Nestler EJ. 2008. The molecular neurobiology of depression. Nature 455:894-902.
37. Leake A, Fairbairn AF, McKeith IG, Ferrier IN. 1991. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates. Psychiatry Res 39:155-165.
38. Lein ES, Zhao X, Gage FH. 2004. Defining a molecular atlas of the hippocampus using DNA microarrays and high-throughput in situ hybridization. J Neurosci 24:3879-3889.
39. Lucki I, Dalvi A, Mayorga AJ. 2001. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155:315-322.
40. MacQueen GM, Campbell S, McEwen BS, Macdonald K, Amano S, Joffe RT, Nahmias C, Young LT. 2003. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 100:1387-1392.
41. Macri S, Granstrem O, Shumilina M, Antunes Gomes dos Santos FJ, Berry A, Saso L, Laviola G. 2009. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Horm Behav 56:391-398.
42. Maines LW, Keck BJ, Smith JE, Lakoski JM. 1999. Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Synapse 32:58-66.
43. McKittrick CR, Magarinos AM, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. 2000. Chronic social stress reduces dendritic arbors in CA3 of hippocampus and decreases binding to serotonin transporter sites. Synapse 36:85-94.
44. Mirescu C, Gould E. 2006. Stress and adult neurogenesis. Hippocampus 16:233-238.
45. Moser MB, Moser EI. 1998. Functional differentiation in the hippocampus. Hippocampus 8:608-619.
46. Naumenko VS, Kondaurova EM, Bazovkina DV, Tsybko AS, Tikhonova MA, Kulikov AV, Popova NK. 2013. Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains. Neuroscience 214:59-67.
47. Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A. 2005. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med 46:973-977.
48. Newberg AB, Amsterdam JD, Wintering N, Shults J. 2012. Low brain serotonin transporter binding in major depressive disorder. Psychiatry Res 202:161-167.
49. O'Hara R, Schroder CM, Mahadevan R, Schatzberg AF, Lindley S, Fox S, Weiner M, Kraemer HC, Noda A, Lin X, Gray HL, Hallmayer JF. 2007. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol. Mol Psychiatry 12:544-555.
50. Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, Huang Y, Ogden RT, Van Heertum RL, Arango V, Mann JJ. 2006. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 163:52-58.
51. Pitkanen A, Pikkarainen M, Nurminen N, Ylinen A. 2000. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat. A review. Ann NY Acad Sci 911:369-391.
52. Pollak DD, Rey CE, Monje FJ. 2010. Rodent models in depression research: Classical strategies and new directions. Ann Med 42:252-264.
53. Porsolt RD, Le Pichon M, Jalfre M. 1977. Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732.
54. Reus VI, Miner C. 1985. Evidence for physiological effects of hypercortisolemia in psychiatric patients. Psychiatry Res 14:47-56.
55. Ripoll N, David DJ, Dailly E, Hascoet M, Bourin M. 2003. Antidepressant-like effects in various mice strains in the tail suspension test. Behav Brain Res 143:193-200.
56. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R. 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809.
57. Sapolsky RM. 2000. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935.
58. Savitz JB, Drevets WC. 2012. Neuroreceptor imaging in depression. Neurobiol Dis 52:49-65.
59. Selvaraj S, Murthy NV, Bhagwagar Z, Bose SK, Hinz R, Grasby PM, Cowen PJ. 2011. Diminished brain 5-HT transporter binding in major depression: A positron emission tomography study with [11C]DASB. Psychopharmacology (Berl) 213:555-562.
60. Sharp T, Cowen PJ. 2011. 5-HT and depression: is the glass half-full? Curr Opin Pharmacol 11:45-51.
61. Staley JK, Sanacora G, Tamagnan G, Maciejewski PK, Malison RT, Berman RM, Vythilingam M, Kugaya A, Baldwin RM, Seibyl JP, Charney D, Innis RB. 2006. Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry 59:40-47.
62. Stemmelin J, Cohen C, Yalcin I, Keane P, Griebel G. 2010. Implication of beta3-adrenoceptors in the antidepressant-like effects of amibegron using Adrb3 knockout mice in the chronic mild stress. Behav Brain Res 206:310-312.
63. Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370.
64. Strekalova T, Couch Y, Kholod N, Boyks M, Malin D, Leprince P, Steinbusch HM. 2011. Update in the methodology of the chronic stress paradigm: internal control matters. Behav Brain Funct 7:9.
65. Strekalova T, Gorenkova N, Schunk E, Dolgov O, Bartsch D. 2006. Selective effects of citalopram in a mouse model of stress-induced anhedonia with a control for chronic stress. Behav Pharmacol 17:271-287.
66. Sugimoto Y, Kajiwara Y, Hirano K, Yamada S, Tagawa N, Kobayashi Y, Hotta Y, Yamada J. 2008. Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: Analysis of serotonin and noradrenaline transporter binding. Eur J Pharmacol 592:116-122.
67. Summers TR, Matter JM, McKay JM, Ronan PJ, Larson ET, Renner KJ, Summers CH. 2003. Rapid glucocorticoid stimulation and GABAergic inhibition of hippocampal serotonergic response: in vivo dialysis in the lizard anolis carolinensis. Horm Behav 43:245-253.
68. Swanson LW, Cowan WM. 1977. An autoradiographic study of the organization of the efferent connections of the hippocampal formation in the rat. J Comp Neurol 172:49-84.
69. Tang M, Lei J, Sun X, Liu G, Zhao S. 2013. Stress-induced anhedonia correlates with lower hippocampal serotonin transporter protein expression. Brain Res.
70. Thoeringer CK, Sillaber I, Roedel A, Erhardt A, Mueller MB, Ohl F, Holsboer F, Keck ME. 2007. The temporal dynamics of intrahippocampal corticosterone in response to stress-related stimuli with different emotional and physical load: An in vivo microdialysis study in C57BL/6 and DBA/2 inbred mice. Psychoneuroendocrinology 32:746-757.
71. Videbech P, Ravnkilde B. 2004. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 161:1957-1966.
72. Williams MT, Schaefer TL, Ehrman LA, Able JA, Gudelsky GA, Sah R, Vorhees CV. 2005. 3, 4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity. Brain Res 1039:97-107.
73. Yan HC, Cao X, Das M, Zhu XH, Gao TM. 2010. Behavioral animal models of depression. Neurosci Bull 26:327-337.
74. Zhao Y, Ma R, Shen J, Su H, Xing D, Du L. 2008. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 581:113-120.
75. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. 2010. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35:2510-2520.